Skip to main navigation
Skip to search
Skip to main content
MD Anderson Cancer Center Home
Help & FAQ
Home
Profiles
Research units
Equipment
Research output
Activities
Prizes
Search by expertise, name or affiliation
New pieces in the BTKi resistance puzzle
Jan A. Burger
Leukemia
Research output
:
Contribution to journal
›
Review article
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'New pieces in the BTKi resistance puzzle'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Diffuse Large B-cell Lymphoma Cells
100%
Ibrutinib Resistance
100%
BTKi
100%
Supernatant
50%
Signaling Pathway
50%
Interleukin-6
50%
Survival Benefit
50%
Novel Mechanism
50%
Point mutation
50%
Interleukin-10
50%
Paracrine
50%
Resistance mutations
50%
Pro-survival
50%
ERK2
50%
ERK Activation
50%
Malignant B Cells
50%
Ibrutinib
50%
Cell-cell Contact
50%
Micropore Filter
50%
Medicine and Dentistry
Waldenström's Macroglobulinemia
100%
Ibrutinib
100%
Diffuse Large B-Cell Lymphoma
66%
B Cell Lymphoma Cell
66%
Cell Signaling Pathway
33%
Cytokine
33%
Interleukin 6
33%
Mitogen Activated Protein Kinase 3
33%
Point Mutation
33%
B Cell
33%
Secretion (Process)
33%
Cell Contact
33%
Interleukin 10
33%
Resistance Mutation
33%
Immunology and Microbiology
Macroglobulinemia
100%
B Cell Lymphoma Cell
66%
Cytokine
33%
Interleukin 6
33%
Interleukin 10
33%
Supernatant
33%
Wild Type
33%
Point Mutation
33%
B Cell
33%
Cell Contact
33%
Secretion (Process)
33%
Pharmacology, Toxicology and Pharmaceutical Science
Waldenstroem macroglobulinemia
100%
Ibrutinib
100%
Diffuse Large B Cell Lymphoma
66%
Cytokine
33%
Interleukin 6
33%
Interleukin 10
33%
Mitogen Activated Protein Kinase 3
33%
Engineering
Carrying Cell
33%
Micropore
33%